Differential modulation by baclofen on antinociception induced by morphineand beta-endorphin administered intracerebroventricularly in the formalin test
Km. Chung et al., Differential modulation by baclofen on antinociception induced by morphineand beta-endorphin administered intracerebroventricularly in the formalin test, NEUROPEPTID, 33(6), 1999, pp. 534-541
Our previous studies have demonstrated that supraspinal GABAergic receptors
are differentially involved in the antinociception induced by morphine and
beta-endorphin given intracerebroventricularly (i.c.v.) in the tail-flick
and hot-plate tests. These two models employed a phasic, thermal nociceptiv
e stimulus, The present study was designed to examine the possible involvem
ent of supraspinal GABAergic receptors in opioid-induced antinociception in
the formalin test. Morphine (1 mu g) and beta-endorphin (1 mu g) given i.c
.v. displayed the almost complete inhibitory effects against the hyperalges
ic response in both phases. Muscimol (75-100 ng) and baclofen (5-10 ng) inj
ected i.c.v. produced the hypoalgesic response in the both phases. The hypo
algesic response induced by muscimol and baclofen observed during the secon
d phase was more pronounced than that observed during the second phase. Bac
lofen (2.5 ng), at the dose which did not affect the hyperalgesic response,
resulted in a significant reversal of the i.c.v. administered beta-endorph
in-induced hypoalgesic response observed during the second, but not the fir
st, phase, However, the hypoalgesic response induced by i.c.v, administered
morphine was not changed by the same dose of muscimol or baclofen injected
i.c.v. Our results indicate that, at the supraspinal level, GABA(B) recept
ors appear to be involved in the modulation of antinociception induced by s
upraspinally administered beta-endorphin, but not morphine, in the formalin
test model. (C) 1999 Harcourt Publishers Ltd.